Jefferies Financial Group Inc. acquired a new position in shares of Anterix Inc. (NASDAQ:ATEX – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 454,508 shares of the company’s stock, valued at approximately $9,922,000. Jefferies Financial Group Inc. owned approximately 2.43% of Anterix as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. SG Americas Securities LLC bought a new stake in Anterix during the 4th quarter worth approximately $1,059,000. GABELLI & Co INVESTMENT ADVISERS INC. increased its holdings in Anterix by 219.3% during the 3rd quarter. GABELLI & Co INVESTMENT ADVISERS INC. now owns 52,200 shares of the company’s stock worth $1,121,000 after purchasing an additional 35,850 shares in the last quarter. SBI Securities Co. Ltd. increased its holdings in Anterix by 374,815.0% during the 3rd quarter. SBI Securities Co. Ltd. now owns 74,983 shares of the company’s stock worth $1,610,000 after purchasing an additional 74,963 shares in the last quarter. Gamco Investors INC. ET AL increased its holdings in Anterix by 17.1% during the 3rd quarter. Gamco Investors INC. ET AL now owns 320,070 shares of the company’s stock worth $6,872,000 after purchasing an additional 46,645 shares in the last quarter. Finally, GSA Capital Partners LLP grew its holdings in shares of Anterix by 22.3% in the fourth quarter. GSA Capital Partners LLP now owns 72,976 shares of the company’s stock valued at $1,593,000 after acquiring an additional 13,324 shares in the last quarter. 87.67% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
ATEX has been the subject of several recent analyst reports. Weiss Ratings raised Anterix from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, April 21st. Zacks Research lowered Anterix from a “strong-buy” rating to a “hold” rating in a report on Thursday, February 5th. One investment analyst has rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $50.00.
Anterix Stock Performance
Shares of NASDAQ ATEX opened at $63.57 on Monday. The stock has a fifty day simple moving average of $44.90 and a two-hundred day simple moving average of $32.33. Anterix Inc. has a 1-year low of $17.58 and a 1-year high of $64.00. The firm has a market cap of $1.19 billion, a price-to-earnings ratio of 14.61 and a beta of 0.86.
Anterix Profile
Anterix, Inc is a specialized telecommunications company focused on delivering private broadband networks for utilities and other critical infrastructure industries. The company owns and operates dedicated 900 MHz spectrum that enables reliable, secure and high-performance wireless communications to support grid modernization, smart metering, distribution automation and other mission-critical applications. By leveraging this spectrum, Anterix helps electric, water and gas utilities deploy advanced communications capabilities to enhance operational efficiency and resiliency.
At the core of Anterix’s offering is its licensed 900 MHz spectrum, which provides superior propagation characteristics compared with unlicensed options and allows for cost-effective coverage over expansive service territories.
Recommended Stories
- Five stocks we like better than Anterix
- The Smart Glasses Gold Rush Is Leaving Old-School Eyewear Behind
- 3 Rare Earth Stocks That Win No Matter What China Does Next
- Amylyx Stock: Why the Full Pipeline Story Matters
- Palantir and Dell Build an AI OS for the Paranoid
Want to see what other hedge funds are holding ATEX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Anterix Inc. (NASDAQ:ATEX – Free Report).
Receive News & Ratings for Anterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anterix and related companies with MarketBeat.com's FREE daily email newsletter.
